Zelira in the news
Articles
For media related enquiries please contact Damien Carbon at Profile Media
Ph: +61 (0) 412 332 122 E: damienc@profilemedia.com.au
Zelda Therapeutics to outline cannabinoid-based strategy at Proactive CEO Sessions
Zelda Therapeutics Ltd (ASX:ZLD) is developing a range of cannabinoid-based formulations for the treatment of a variety of medical conditions, with a focus on cancer therapies.
Zelda Therapeutics to outline cannabinoid-based strategy at Proactive CEO Sessions